AChE inhibitors are vital in treating symptoms of neurodegenerative conditions such as Alzheimer’s disease, which are characterized by a significant decline in cholinergic function [7]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.